Intensity-Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma: An Adaptation of 2-Dimensional Concepts or a Reconsideration of Current Clinical Practice

Seminars in Radiation Oncology

Volumn 14, Issue 2, 2004, Pages 110-120

  Grégoire, Vincent ^a   Maingon, Philippe ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CLINICAL PRACTICE; COMORBIDITY; DOSIMETRY; HEAD AND NECK CANCER; HUMAN; IMAGING SYSTEM; IMMOBILIZATION; INTENSITY MODULATED RADIATION THERAPY; LIFESTYLE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION BEAM; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; REVIEW; SECOND CANCER; SQUAMOUS CELL CARCINOMA;

EID: 2342624111     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semradonc.2003.12.006     Document Type: Article

References (51)

1. Mell LK, Roeske JC, Mundt AJ: A survey of intensity-modulated radiation therapy use in the United States. Cancer 98:204-211, 2003
2. Claus F, Boterberg T, Ost P, et al: Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome? Radiother Oncol 64:205-208, 2002
3. Lee N, Xia P, Quivey JM, et al: Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12-22, 2002
4. Eisbruch A, Ten Haken RK, Kim HM, et al: Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45:577-587, 1999
5. Eisbruch A, Kim HM, Terrell JE, et al: Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50: 695-704, 2001
6. Chao KS, Majhail N, Huang CJ, et al: Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol 61:275-280, 2001
7. Henson BS, Inglehart MR, Eisbruch A, et al: Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol 37:84-93, 2001
8. Dawson LA, Anzai Y, Marsh L, et al: Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46:1117-1126, 2000
9. Chao KS, Wippold FJ, Ozyigit G, et al: Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53:1174-1184, 2002
10. Chao KS, Ozyigit G, Tran BN, et al: Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55: 312-321, 2003
11. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near the base of the skull following IMRT of head and neck cancer: Implications for target delineation in the high neck, and for parotid sparing. Int J Radiat Oncol Biol Phys (in press)
12. IGRU Report 50. Dose specification for reporting external beam therapy with photons and electrons. International Comission on Radiation Units and Measurements, Washington, DG (IGRU Report, September 1993)
13. IGRU Report 62. Prescribing, recording and reporting photon beam therapy (supplement to IGRU report 50). International Commission on Radiation Units and Measurements, Washington, DC (IGRU Report, November 1999)
14. van Asselen B, Raaijmakers CP, Lagendijk JJ, et al: Intrafraction motions of the larynx during radiotherapy. Int J Radiat Oncol Biol Phys 56:384-390, 2003
15. Gilbeau L, Octave-Prignot M, Loncol T, et al: Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors. Radiother Oncol 58:155-162, 2001
16. van Herk M, Remeijer P, Rasch C, et al: The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47:1121-1135, 2000
17. de Boer HC, van Sornsen de Koste JR, Creutzberg CL, et al: Electronic portal image assisted reduction of systematic set-up errors in head and neck irradiation. Radiother Oncol 61:299-308, 2001
18. Samuelsson A, Mercke C, Johansson KA: Systematic set-up errors for IMRT in the head and neck region: Effect on dose distribution. Radiother Oncol 66:303-311, 2003
19. Manning MA, Wu Q, Cardinale RM, et al: The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 51: 1400-1409, 2001
20. McKenzie A, van Herk M, Mijnheer B: Margins for geometric uncertainty around organs at risk in radiotherapy. Radiother Oncol 62:299-307, 2002
21. Eisbruch A, Foote RL, O'Sullivan B, et al: Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets. Semin Radiat Oncol 12:238-249, 2002
22. Grégoire V, Coche E, Cosnard G, et al: Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56:135-150, 2000
23. Nowak PJ, Wijers OB, Lagerwaard FJ, et al: A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys 45:33-39, 1999
24. Wijers OB, Levendag PC, Tan T, et al: A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol 52:35-42, 1999
25. Grégoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related GTVs in the node negative neck: DAHANCA, EORTC, GORTEC, RTOG consensus guidelines. Radiother Oncol 69:227-236, 2003
26. Levendag P, Braaksma M, Coche E, et al. Rotterdam and Brussels CT-based neck nodal delineation compared to the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. Int J Radiat Oncol Biol Phys 58:113-123, 2004
27. Daisne JF, Duprez T, Weynant B, et al: Impact of image coregistration with computed tomography (CT), magnetic resonance (MR) and positron emission tomography with fluorodeoxyglucose (FDG-PET) on delineation of GTV's in oropharyngeal, laryngeal and hypopharyngeal tumors. Int J Radiat Oncol Biol Phys 54:15-16, 2002
28. Daisne JF, Duprez T, Weynant B, et al. Accuracy of CT scan, MRI and FDG-PET in delineating the tumor volume in pharyngo-laryngeal squamous cell carcinomas treated by radiotherapy: Comparison between modalities and validation with the macroscopic tumor specimen used as reference. Radiology (in press)
29. Chao KS, Bosch WR, Mutic S, et al: A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49:1171-1182, 2001
30. Ling CC, Humm J, Larson S, et al: Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47: 551-560, 2000
31. Dogan N: Improvement of treatment plans developed with intensity modulated radiation therapy for concave shaped head and neck tumors. Radiology 223:57-64, 2002
32. Fogliata A, Bolsi A, Cozzi L: Comparative analysis of intensity modulation inverse planning modules of 3 commercial treatment planning systems applied to head and neck tumor model. Radiother Oncol 66:29-40, 2003
33. Samuelsson A, Johansson KA: Intensity modulated radiation therapy treatment planning for dynamic multi-leaf collimator delivery: Influence of different parameters on dose distribution. Radiother Oncol 66:19-28, 2003
34. Rowbottom CG, Nutting CM, Webb S: Beam orientation optimization of intensity modulated radiotherapy: Clinical application to parotid gland tumors. Radiother Oncol 59:169-177, 2001
35. Wolden SL, Zelefsky MJ, Hunt MA, et al: Failure of a 3-D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 49:1229-1234, 2001
36. Hunt MA, Zelefsky MJ, Wolden SL: Treatment planning and delivery of intensity modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 49:623-632, 2001
37. Butler EB, Tteh BS, Grant WH, et al: SMART (simultaneous modulated accelerated radiation therapy) boost: A new accelerated fractionation. Int J Radiat Oncol Biol Phys 45:21-32, 1999
38. Mohan R, Wu Q, Manning M, et al: Radiobiological considerations in the design of fractionation strategies for intensity modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 46:619-630, 2000
39. Vineberg KA, Eisbruch A, Coselmon MM, et al: Is uniform target dose possible in IMRT plans in the head and neck? Int J Radiat Oncol Biol Phys 52:1159-1172, 2002
40. Withers HR, Thames HD: Dose fractionation and volume effects in normal tissues and tumors. Am J Clin Oncol 11:313-329, 1988
41. Niemierko A: Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 24:103-110, 1997
42. Wu Q, Mohan R, Niemierko A, et al: Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 52:224-235, 2002
43. Fu KK, Pajak TF, Trotti A, et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16, 2000
44. Bentzen SM: Dose-response relationships in radiotherapy, in Steel GG (ed): Basic clinical radiobiology. London, Arnold, 2002, pp 94-104
45. Williams BC, Hounsella R: X-ray linkage considerations for IMRT. Br J Radiol 74:98-102, 2001
46. Verellen D, Vanhavere F: Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 53:199-203, 1999
47. Hall EJ, Wuu CS: Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56:83-88, 2003
48. LoSasso T, Chui CS, Ling CC: Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy. Med Phys 25:1919-1927, 1998
49. De Neve W, De Gersem W, Derycke S, et al: Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second primary head and neck cancer using a multileaf collimator with dynamic control. Radiother Oncol 50:301-314, 1999
50. van Esch A, Bohsdung J, Sorvari P, et al: Acceptance tests and quality control procedures for the clinical implementation of intensity modulated radiotherapy using inverse planning and the sliding window technique: Experience from five radiotherapy departments. Radiother Oncol 65: 53-70, 2002
51. Bentzen SM, Baumann M: The linear-quadratic model in clinical practice, in Steel GG (ed): Basic Clinical Radiobiology. London, Arnold, 2002, pp 134-146